España
India
Italia
대한민국
日本
My Account
My Account
Notifications
Overview
+ New Watchlist
Benzinga Edge
Benzinga Research
Benzinga Pro
Log In
Get Benzinga Pro
Data & APIs
Events
Marketfy
Premarket
Boost
Advertise
Contribute
España
India
Italia
대한민국
日本
Login
Register
Our Services
News
Earnings
Guidance
Dividends
M&A
Buybacks
Legal
Interviews
Management
Offerings
IPOs
Insider Trades
Biotech/FDA
Politics
Healthcare
Markets
Pre-Market
After Hours
Movers
ETFs
Forex
Cannabis
Commodities
Binary Options
Bonds
Futures
CME Group
Global Economics
Mining
Previews
Small-Cap
Real Estate
Penny Stocks
Digital Securities
Volatility
Options
Ratings
Analyst Color
Downgrades
Upgrades
Initiations
Price Target
Ideas
Trade Ideas
Long Ideas
Short Ideas
Technicals
From The Press
Jim Cramer
Rumors
Whisper Index
Stock of the Day
Best Stocks & ETFs
Best Penny Stocks
Best S&P 500 ETFs
Best Swing Trade Stocks
Best Blue Chip Stocks
Best High-Volume Penny Stocks
Best Small Cap ETFs
Best Stocks to Day Trade
Best REITs
Money
Investing
Cryptocurrency
Mortgage
Insurance
Yield
Personal Finance
Forex
Startup Investing
Real Estate Investing
Prop Trading
Credit Cards
Stock Brokers
Crypto
Cannabis
Cannabis Conference
Earnings
Interviews
Deals
Regulations
Psychedelics
Markets
Pre-Market
After Hours
Movers
ETFs
Forex
Cannabis
Commodities
Binary Options
Bonds
Futures
CME Group
Global Economics
Mining
Previews
Small-Cap
Real Estate
Penny Stocks
Digital Securities
Volatility
Options
Ratings
Analyst Color
Downgrades
Upgrades
Initiations
Price Target
Ideas
Trade Ideas
Long Ideas
Short Ideas
Technicals
From The Press
Jim Cramer
Rumors
Whisper Index
Stock of the Day
Best Stocks & ETFs
Best Penny Stocks
Best S&P 500 ETFs
Best Swing Trade Stocks
Best Blue Chip Stocks
Best High-Volume Penny Stocks
Best Small Cap ETFs
Best Stocks to Day Trade
Best REITs
Money
Investing
Cryptocurrency
Mortgage
Insurance
Yield
Personal Finance
Forex
Startup Investing
Real Estate Investing
Prop Trading
Credit Cards
Stock Brokers
Crypto
Cannabis
Cannabis Conference
Earnings
Interviews
Deals
Regulations
Psychedelics
Research
My Stocks
Tools
Free Benzinga Pro Trial
Calendars
Analyst Ratings Calendar
Conference Call Calendar
Dividend Calendar
Earnings Calendar
Economic Calendar
FDA Calendar
Guidance Calendar
IPO Calendar
M&A Calendar
SPAC Calendar
Stock Split Calendar
Trade Ideas
Free Stock Reports
Insider Trades
Trade Idea Feed
Analyst Ratings
Unusual Options Activity
Heatmaps
Free Newsletter
Government Trades
Perfect Stock Portfolio
Easy Income Portfolio
Short Interest
Most Shorted
Largest Increase
Largest Decrease
Calculators
Margin Calculator
Forex Profit Calculator
100x Options Profit Calculator
Recent
Markets
Comments
Close menu
Loading...
Iterum Therapeutics
ITRM
NASDAQ
Watchlist
Leave a Comment
Logo brought to you by Benzinga Data
Get Report
Perks
Buy
Compare Brokers
Get Report
Perks
Buy
Compare Brokers
$1.52
0.1
7.04%
At close: -
$1.50
-0.02
-1.32%
After Hours: 7:55 PM EDT
Get Report
Comment
Q3 2024 Earnings were released on Thu Nov 14th, before the market open
The most recent conference call was at 8:30 AM, 5 days ago
Click to view past webcast
Iterum Therapeutics (ITRM) Forecast
News
Earnings
Iterum Therapeutics (ITRM) Options
Guidance
Dividends
Analyst Ratings
Insider Trades
Short Interest
Latest news for Iterum Therapeutics (NASDAQ:ITRM) Stock
Iterum Therapeutics Stock (NASDAQ: ITRM)
Categories: All
All News
General
Contracts
Dividends
Events
FDA
M&A
Offerings
Stock Split
Media
Buybacks
Insider Trades
Earnings
Guidance
Analyst Ratings
Trading Ideas
All News
General
Contracts
Dividends
Events
FDA
M&A
Offerings
Stock Split
Media
Buybacks
Insider Trades
Earnings
Guidance
Analyst Ratings
Trading Ideas
Thursday, November 14, 2024
Iterum Therapeutics Q3 2024 Adj. EPS $(0.24) ...
Benzinga Newsdesk
Earnings Scheduled For November 14, 2024
Benzinga Insights
Wednesday, November 13, 2024
A Look at Iterum Therapeutics's Upcoming Earnings Report
Benzinga Insights
Friday, November 01, 2024
Iterum Therapeutics Notified Pfizer, Electing...
Benzinga Newsdesk
Monday, October 28, 2024
12 Health Care Stocks Moving In Monday's Intraday Session
Benzinga Insights
FDA Approval Of Orlynvah For Urinary Tract Infections Marks Milestone For Iterum, Paves Way For New Strategic Partnerships
Vandana Singh
Iterum Therapeutics Wins FDA Approval for Fir...
Benzinga Newsdesk
Friday, October 25, 2024
12 Health Care Stocks Moving In Friday's Intraday Session
Benzinga Insights
Iterum Therapeutics Shares Resume Trading
Benzinga Newsdesk
CORRECTION: Iterum Therapeutics Shares To Res...
Benzinga Newsdesk
Trading Halt: Halt status updated at 11:25:00...
Benzinga Newsdesk
Iterum Therapeutics shares are trading higher...
Benzinga Newsdesk
FDA Approves Iterum Therapeutics' NDA For ORL...
Benzinga Newsdesk
Trading Halt: Halted at 10:49:27 a.m. ET - Tr...
Benzinga Newsdesk
Tuesday, September 10, 2024
Trading Halt: Halt status updated at 7:25:00 ...
Benzinga Newsdesk
Iterum Therapeutics Reports FDA Advisory Comm...
Benzinga Newsdesk
HC Wainwright & Co. Reiterates Buy on Iterum ...
Benzinga Newsdesk
Monday, September 09, 2024
Trading Halt: Halted at 6:55:00 a.m. ET - Tra...
Benzinga Newsdesk
Thursday, August 15, 2024
HC Wainwright & Co. Maintains Buy on Iterum T...
Benzinga Newsdesk
Wednesday, August 14, 2024
Iterum Therapeutics Q2 2024 Adj. EPS $(0.23) ...
Benzinga Newsdesk
Friday, August 09, 2024
Iterum Therapeutics shares are trading higher...
Benzinga Newsdesk
Tuesday, August 06, 2024
Iterum Therapeutics Announces Expiration And ...
Benzinga Newsdesk
Friday, August 02, 2024
Iterum Therapeutics Announces USPTO Notice Of...
Benzinga Newsdesk
Monday, July 22, 2024
Iterum Therapeutics Commences $1.21 Per Unit ...
Benzinga Newsdesk
Friday, June 21, 2024
HC Wainwright & Co. Reiterates Buy on Iterum ...
Benzinga Newsdesk
Iterum Therapeutics Announces FDA To Review N...
Benzinga Newsdesk
Friday, May 31, 2024
HC Wainwright & Co. Reiterates Buy on Iterum ...
Benzinga Newsdesk
Iterum Therapeutics shares are trading higher...
Benzinga Newsdesk
Iterum Therapeutics Announced That The U.S. F...
Benzinga Newsdesk
Tuesday, May 14, 2024
HC Wainwright & Co. Reiterates Buy on Iterum ...
Benzinga Newsdesk
Monday, May 13, 2024
Iterum Therapeutics' Cash, Cash Equivalents A...
Benzinga Newsdesk
Iterum Therapeutics Q1 2024 Adj EPS $(0.58) B...
Benzinga Newsdesk
Tuesday, April 30, 2024
HC Wainwright & Co. Reiterates Buy on Iterum ...
Benzinga Newsdesk
Monday, April 29, 2024
Iterum Therapeutics Resubmits New Drug Applic...
Benzinga Newsdesk
Friday, April 05, 2024
On April 3, Iterum Therapeutics Received Lett...
Benzinga Newsdesk
Monday, April 01, 2024
HC Wainwright & Co. Reiterates Buy on Iterum ...
Benzinga Newsdesk
Thursday, March 28, 2024
Update: Iterum Therapeutics Q4 Adjusted EPS $...
Benzinga Newsdesk
Iterum Therapeutics Q4 Adj EPS $(0.81) Beats ...
Benzinga Newsdesk
Earnings Scheduled For March 28, 2024
Benzinga Insights
Wednesday, March 27, 2024
Iterum Therapeutics's Earnings: A Preview
Benzinga Insights
Wednesday, March 20, 2024
12 Health Care Stocks Moving In Wednesday's After-Market Session
Benzinga Insights
Wednesday, March 06, 2024
HC Wainwright & Co. Reiterates Buy on Iterum ...
Benzinga Newsdesk
Iterum Therapeutics Provides Updates; Expects...
Benzinga Newsdesk
Tuesday, February 13, 2024
12 Health Care Stocks Moving In Tuesday's Pre-Market Session
Benzinga Insights
Wednesday, February 07, 2024
HC Wainwright & Co. Upgrades Iterum Therapeut...
Benzinga Newsdesk
Tuesday, January 30, 2024
12 Health Care Stocks Moving In Tuesday's After-Market Session
Benzinga Insights
Why Iterum Therapeutics Stock Is Trending Today
Erica Kollmann
Iterum Therapeutics shares are trading higher...
Benzinga Newsdesk
12 Health Care Stocks Moving In Tuesday's Pre-Market Session
Benzinga Insights
Trading Halt: Halt status updated at 7:25:00 ...
Benzinga Newsdesk
Show More
Create a Watchlist
FREE: Follow your stocks and cryptocurrencies with the most actionable alerts on the internet.
Click to Get Started
People Also Watch